We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ACE inhibitor

News List

Top Perindopril Erbumine API Manufacturers in China PharmaSources
May 17, 2021
Perindopril erbumine is the tert-butylamine salt of a third generation long-acting angiotensin-converting enzyme (ACE) inhibitor, perindopril, the free acid form of perindopril erbumine.
Blood-pressure drugs are in the crosshairs of COVID-19 research expresspharma
April 23, 2020
A disproportionate number of patients hospitalised by COVID-19, the disease caused by the virus, have high blood pressure.
Entresto tops mainstay ACE inhibitor in heart failure trial pharmaphorum
December 04, 2018
Two years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope of revving up disappointing initial sales, and one of those trials has just delivered positive results.